Latest period
$903.00M
YoY change
+7.1%
5Y CAGR
+6.8%
Peak year (2025)
$894.00M
Latest annual
$894.00M
Stock-Based Compensation history chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: $894.00M
Stock-Based Compensation growth chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: +7.1%
Stock-Based Compensation history table for Gilead Sciences (GILD) from 1990 to 2025
| 2025 | $894.00M | +7.1% | +$59.00M | ||
| 2024 | $835.00M | +9.0% | +$69.00M | ||
| 2023 | $766.00M | +18.9% | +$122.00M | ||
| 2022 | $644.00M | +1.4% | +$9.00M | ||
| 2021 | $635.00M | -1.2% | −$8.00M | ||
| 2020 | $643.00M | +1.1% | +$7.00M | ||
| 2019 | $636.00M | -24.7% | −$209.00M | ||
| 2018 | $845.00M | +32.4% | +$207.00M | ||
| 2017 | $638.00M | +67.9% | +$258.00M | ||
| 2016 | $380.00M | -0.5% | −$2.00M | ||
| 2015 | $382.00M | +6.1% | +$22.00M | ||
| 2014 | $360.00M | +42.9% | +$108.00M | ||
| 2013 | $252.00M | +20.6% | +$43.00M | ||
| 2012 | $209.00M | +8.6% | +$16.62M | ||
| 2011 | $192.38M | -3.8% | −$7.66M | ||
| 2010 | $200.04M | +10.7% | +$19.36M | ||
| 2009 | $180.68M | +17.8% | +$27.32M | ||
| 2008 | $153.36M | — | +$153.36M | ||
| 2007 | $0.00 | — | $0.00 | ||
| 2006 | $0.00 | — | $0.00 | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | $0.00 | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | $0.00 | ||
| 2000 | $0.00 | — | $0.00 | ||
| 1999 | $0.00 | — | $0.00 | ||
| 1998 | $0.00 | — | $0.00 | ||
| 1997 | $0.00 | — | $0.00 | ||
| 1996 | $0.00 | — | $0.00 | ||
| 1995 | $0.00 | — | $0.00 | ||
| 1994 | $0.00 | — | — | ||
| 1992 | $0.00 | — | $0.00 | ||
| 1991 | $0.00 | — | $0.00 | ||
| 1990 | $0.00 | — | — |
- 2025$894.00M+7.1%
- 2024$835.00M+9.0%
- 2023$766.00M+18.9%
- 2022$644.00M+1.4%
- 2021$635.00M-1.2%
- 2020$643.00M+1.1%
- 2019$636.00M-24.7%
- 2018$845.00M+32.4%
- 2017$638.00M+67.9%
- 2016$380.00M-0.5%
- 2015$382.00M+6.1%
- 2014$360.00M+42.9%
- 2013$252.00M+20.6%
- 2012$209.00M+8.6%
- 2011$192.38M-3.8%
- 2010$200.04M+10.7%
- 2009$180.68M+17.8%
- 2008$153.36M—
- 2007$0.00—
- 2006$0.00—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00—
- 2002$0.00—
- 2001$0.00—
- 2000$0.00—
- 1999$0.00—
- 1998$0.00—
- 1997$0.00—
- 1996$0.00—
- 1995$0.00—
- 1994$0.00—
- 1992$0.00—
- 1991$0.00—
- 1990$0.00—
Stock-Based Compensation values are taken from Gilead Sciences's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Gilead Sciences (GILD)
Stock-Based Compensation for Gilead Sciences (GILD): headline value $903.00M · YoY +7.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Gilead Sciences (GILD) stock-based compensation totalled $894.00M – grew 7.1% year-over-year.
Gilead Sciences stock-based compensation has grown on net over the period, with a +6.8% compound annual growth rate over 2020–2025 (5 years).
$894.00M stands as the all-time-high annual stock-based compensation, posted in 2025, against a low of $0.00 during 1990.
Gilead Sciences Stock-Based Compensation by Year
Gilead Sciences Stock-Based Compensation 2025: $894.00M
2025's stock-based compensation for Gilead Sciences came in at $894.00M, grew 7.1% from 2024. This figure represents the highest annual value in the available history.
Gilead Sciences Stock-Based Compensation 2024: $835.00M
Gilead Sciences posted stock-based compensation of $835.00M in 2024, grew 9.0% from 2023.
Gilead Sciences Stock-Based Compensation 2023: $766.00M
In 2023, Gilead Sciences reported stock-based compensation of $766.00M, grew 18.9% from 2022.
Gilead Sciences Stock-Based Compensation 2022: $644.00M
Gilead Sciences stock-based compensation in 2022 was $644.00M, edged up 1.4% from 2021.
Gilead Sciences Stock-Based Compensation 2021: $635.00M
Gilead Sciences stock-based compensation in 2021 was $635.00M.
See more financial history for Gilead Sciences (GILD).
Sector peers by Stock-Based Compensation
Healthcare peers of Gilead Sciences (GILD), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation